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The human coronavirus HCoV-OC43 causes a significant fraction of upper respiratory tract infections. Most coronaviruses show a strong
species specificity, although the SARS-Coronavirus crossed species from palm civet cats to infect humans. Similarly, HCoV-OC43, likely a
member of the same coronavirus group as SARS-CoV, readily crossed the species barrier as evidenced by its rapid adaptation to the murine
brain [McIntosh, K., Becker, W.B., Chanock, R.M., 1967. Growth in suckling-mouse brain of ‘‘IBV-like’’ viruses from patients with upper
respiratory tract disease. Proc. Natl. Acad. Sci. U.S.A. 58, 2268–73]. Herein, we investigated two consequences of this plasticity in species
tropism. First, we showed that HCoV-OC43 was able to infect cells from a large number of mammalian species. Second, we showed that virus
that was passed exclusively in suckling mouse brains was highly virulent and caused a uniformly fatal encephalitis in adult mice. The surface
glycoprotein is a major virulence factor in most coronavirus infections. We identified three changes in the HCoV-OC43 surface glycoprotein
that correlated with enhanced neurovirulence in mice; these were located in the domain of the protein responsible for binding to host cells.
These data suggest that some coronaviruses, including HCoV-OC43 and SARS-CoV, readily adapt to growth in cells from heterologous
species. This adaptability has facilitated the isolation of HCoV-OC43 viral variants with markedly differing abilities to infect animals and tissue
culture cells.
D 2005 Elsevier Inc. All rights reserved.Keywords: Coronavirus; Rodent model; EncephalitisIntroduction
Until recently, human coronaviruses were mostly associated
with mild upper respiratory tract infections (‘‘the common
cold’’), and occasionally with outbreaks of gastroenteritis
(Vabret et al., 2003). However, with the recognition that the
Severe Acute Respiratory Syndrome (SARS) was caused by a
coronavirus, it became apparent that coronaviruses could also
cause more significant disease in the human population
(Drosten et al., 2003; Fouchier et al., 2003). Since then, two
additional coronaviruses, HCoV-NL63 and HCoV-HKU1, have
been identified; these agents cause upper and lower respiratory0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: stanley-perlman@uiowa.edu (S. Perlman).tract diseases that are much less severe than SARS (van der
Hoek et al., 2004; Woo et al., 2005).
HCoV-OC43 and HCoV-229E are the etiological agents for
many coronavirus-induced upper respiratory tract infections.
HCoV-OC43, harvested from a patient with an upper respira-
tory tract infection, was originally isolated after passage in
human embryonic tracheal organ cultures; this virus caused
neurological disease after only one passage in suckling mice
and encephalitis within 2–4 passages (McIntosh et al., 1967)
(termed HCoV-OC43NV). HCoV-OC43NV was then propagated
in tissue culture cells generating a tissue culture-adapted
variant (termed HCoV-OC43TC).
HCoV-OC43 showed increasing neurovirulence with pas-
sage through the murine brain (McIntosh et al., 1967);
however, most recent studies have used CNS-adapted viruses
that were further propagated, at least for a few passages, in6) 410 – 421
www.e
Fig. 1. HCoV-OC43NV is uniformly lethal to wild type C57BL/6 mice. 5-week-
old mice were inoculated intranasally with 30 LD50 HCoV-OC43NV or 10
6
TCID50 HCoV-OC43TC as described in Materials and methods. Mice were
monitored daily for survival (A) and weight loss (B). (*Indicates P < 0.0002).
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showed, using the mouse-adapted virus after passage in tissue
culture cells (termed HCoV-OC43QUE herein;) that mice
infected intranasally with 104–105 TCID50 developed enceph-
alitis if inoculated 8 days but not 21 days postnatally (Jacomy
and Talbot, 2003). HCoV-OC43QUE was passaged 5–6 times in
tissue culture prior to use in mice (personal communication, Dr.
Pierre Talbot, INRS-Institut Armand-Frappier, Laval, Quebec)
and consequently may be less virulent than virus isolated
directly from infected suckling mouse brains. Consistent with
this possibility, we observed, in preliminary experiments, that
virus directly harvested from suckling mouse brains caused a
lethal infection after intranasal inoculation of 5- to 8-week-old
mice. Mice died 9–11 days after inoculation, a time when the
adaptive immune response to another coronavirus, mouse
hepatitis virus (MHV), is maximal (Bergmann et al., 1999).
To begin to understand these differences in virulence, we
initiated a more complete study of the disease caused by the
neurovirulent strain of HCoV-OC43.
This ability of HCoV-OC43 to cross species barriers to
infect mice and to gain virulence in the new host contrasts with
the strict species specificity exhibited by most coronaviruses.
For example, the group I coronavirus HCoV-229E does not
readily infect mice, even transgenic mice expressing human
aminopeptidase N, the virus receptor for HCoV-229E (Went-
worth et al., 2005). However, the ability of the group II
coronavirus HCoV-OC43 to adapt easily to replication within
the murine brain suggests that it may be more lax in its species
specificity than other coronaviruses. In that sense, it resembles
another group II coronavirus, SARS-CoV, which likely crossed
the species barrier from animals such as palm civet cats to
infect humans (CSMEC, 2004; Guan et al., 2003; Song et al.,
2005). Unlike other coronaviruses, HCoV-OC43 and the
closely related bovine coronavirus (BCoV) appear to bind to
cells via N-acetyl-neuraminic acid (Schultze and Herrler, 1992;
Vlasak et al., 1988), although there are data to suggest that
HCoV-OC43 can also employ MHC class I antigen as a host
cell receptor (Collins, 1993). This use of a sugar moiety for
entry would also be consistent with the ability to infect a
broader range of species than most coronaviruses. This
possibility was investigated by infecting tissue culture cells
from several different animal species with HCoV-OC43, using
both the mouse-adapted and the tissue culture-adapted strains.
The ability to rapidly gain virulence after passage in the
murine brain is likely to occur via selection of mutations in the
S protein that optimize binding and entry to target cells.
Passage of neurovirulent variants of MHV, in tissue culture,
selects for viruses that are attenuated in vivo but enhanced for
replication in vitro. These changes map to the surface (S)
glycoprotein (Gallagher and Buchmeier, 2001; Tsai et al.,
2003). In addition, infection of rats with uncloned stocks of
MHV resulted in the selection of virulent strains of virus;
again, virulence correlated with changes in the S protein
(Taguchi et al., 1985). Also, replacement of the S gene in the
moderately virulent A59 strain of MHV with the gene
encoding the S protein of the virulent JHM strain resulted in
a gain in virulence in mice (Phillips et al., 1999). In otherstudies, several groups showed that the adaptation of the
SARS-CoV to humans during the 2003 epidemic included
several mutations in the S protein. These mutations were
shown to enhance binding to human angiotensin converting
enzyme 2 (ACE 2), the host cell receptor for SARS-CoV (Kan
et al., 2005; Li et al., 2005). Therefore, to investigate the role of
the S protein in HCoV-OC43 pathogenesis, we sequenced the S
genes of HCoV-OC43TC and HCoV-OC43NVand compared the
results to published sequences of the S genes of several other
HCoV-OC43 isolates.
Results
Intranasal inoculation of HCoV-OC43NV, but not
HCoV-OC43TC, is uniformly fatal to 5- to 8-week-old
C57BL/6 (B6) mice
In confirmation of our preliminary results, intranasal
inoculation of HCoV-OC43NV resulted in 100% mortality in
mice ranging from 5 to 8 weeks old (Fig. 1A). Mice developed
signs of acute encephalitis, including hunched posture, lethargy
and wasting by days 6–7. Mortality was associated with a 30–
35% loss of body mass (Fig. 1B). Severe clinical encephalitis
was associated with widespread mononuclear cell infiltration
including perivascular cuffing and with loss of CNS architec-
ture (data not shown). In contrast, intranasal inoculation of 5-
week-old C57BL/6 mice with HCoV-OC43TC did not cause
any clinical disease, including any weight loss (Fig. 1).
Consistent with the uniformly lethal outcome observed in
N. Butler et al. / Virology 347 (2006) 410–421412mice infected with HCoV-OC43NV, we detected high titers of
virus in the CNS of infected mice. HCoV-OC43NV grew poorly
in tissue culture cells and we could only reliably titer infectious
virus using suckling mice, as described in Materials and
methods. Virus titers increased from days 5 to 7 (Fig. 2). To
confirm these results, we also measured viral loads using a real-
time RT-PCR assay. As shown in Figs. 2A and B, there was a
strong positive correlation between recovery of infectious virus
and the detection of OC43 nucleocapsid RNA in the brains of
mice. Also, and in agreement with the results of Jacomy et al.
(Jacomy and Talbot, 2003), HCoV-OC43 infected other organsFig. 2. Viral titers and viral RNA burdens in the brains of HCoV-OC43NV-infected m
LD50 HCoV-OC43NV. (A and B) Whole brains were isolated at the indicated time
described in Materials and methods. Titers from 3 representative mice are shown for
and viral RNA burden. (C) HCoV-OC43 RNA titers increase until day 7 p.i. then de
for virus burden with real-time RT-PCR. Data in panel C are expressed as mean T SE
Cord’’ versus ‘‘Lung’’ and ‘‘Intestine.’’ (*Indicates P < 0.05).to a small extent, such as the lungs and intestines, when viral
RNAwas assayed by real-time RT-PCR (Fig. 2C). Notably, the
results also suggested that virus was in the process of clearance
at the time of death since virus titers/RNA levels declined
between days 7 and 9 p.i. (Fig. 2C).
In mice infected intranasally with neurovirulent strains of
MHV, virus enters the CNS via the olfactory nerves with
subsequent transneuronal retrograde dissemination to distant
connections of the olfactory bulb (Perlman et al., 1989, 1990).
Using in situ hybridization and immunohistochemistry to track
HCoV-OC43 RNA and antigen, respectively, we detectedice. Wild type and RAG1/ C57BL/6 mice were infected intranasally with 30
points and titers of infectious virus and virus RNA burden were determined as
each time point demonstrating correlation between recovery of infectious virus
cline by day 9. Whole RNAwas isolated from the indicated tissue and assayed
M for 4–6 mice per time point. Note the different scales in ‘‘Brain’’ and ‘‘Spinal
N. Butler et al. / Virology 347 (2006) 410–421 413overlap between the pathways of entry and spread used by
MHV and those used by HCoV-OC43 after intranasal
inoculation. HCoV-OC43 was detected in the olfactory bulb
and the olfactory nucleus at 3 days p.i. but was cleared from
these structures by day 5 p.i. At later time points (days 7 and 9
p.i.), HCoV-OC43 RNA and antigen were detected primarily in
the brainstem and the spinal cord (Fig. 3A, data not shown).
Unlike MHV, which is known to infect oligodendrocytes and is
present throughout the white matter in the infected CNS,
HCoV-OC43 was not detected in the white matter at any time
point examined (shown at day 9 p.i. in Figs. 3A, B).
HCoV-OC43NV infection of mouse CNS is restricted to neurons
The ability of HCoV-OC43NV to cause lethal encephalitis in
adult animals contrasted with that reported for HCoV-
OC43QUE. Jacomy et al. reported that HCoV-OC43QUE
infection was primarily restricted to neurons in vivo (Jacomy
and Talbot, 2003). Thus, one possible explanation for the
enhanced neurovirulence of HCoV-OC43NV, relative to HCoV-
OC43QUE, is an expanded cell tropism. To more directly assess
this possibility, we used combined in situ hybridization and
immunohistochemistry to identify cell types harboring viral
RNA and antigen. We found that viral product was restricted to
cells with morphologies consistent with neurons (Figs. 3C, D).
Moreover, in some animals evaluated at late times postinfection
(day 9), we could clearly identify Purkinje cells that harbored
virus antigen (Fig. 3E). When we evaluated whether astrocytesFig. 3. Neurons are the primary target of HCoV-OC43NV in vivo. Mice were inoculate
harvested 7 or 9 days p.i. Tissue samples were prepared for in situ hybridization, ant
standard light, fluorescence or confocal microscopy as described in Materials and m
cords. Panel A depicts immunohistochemical detection of HCoV-OC43 using the ant
demarcate the white matter. (C–E) Morphology of HCoV-OC43NV-infected cells is
brain stems from mice harvested 7–9 days p.i. Sections were stained with O.4.3 follo
for HCoV-OC43 nucleocapsid RNA (Cy3-labeled antisense probe, red) and immuno
Panel H is a merged image of panels F and G. Original images are 20 magnificawere infected by HCoV-OC43NV in vivo, we found no
evidence of colocalization of HCoV-OC43 RNA and the
astrocyte-specific marker, GFAP antigen (Figs. 3F–H). We
also performed a series of colocalization experiments for viral
RNA and F4/80, a macrophage/microglia-specific cell marker,
but could not identify F4/80+ cells that were positive for viral
product. To confirm these results, we sorted F4/80+CD45hi
(macrophages) and F4/80+CD45int (microglia) cells from the
CNS of infected mice at 7 days postinfection, collected them
onto glass slides and stained them for virus antigen. Neither
macrophages nor microglia stained positive for viral antigen,
while infected tissue culture cells processed in parallel stained
positively (data not shown). These data suggest that unlike
MHV, HCoV-OC43 does not infect astrocytes or macrophages/
microglia. Based on the morphology of the infected cells as
well as the lack of virus staining in the white matter or in
GFAP+ or F4/80+ cells, we conclude that the predominant, if
not sole, targets for HCoV-OC43NV are neurons.
Host adaptive immune response contributes to
HCoV-OC43-induced morbidity and mortality
Viral RNA burden in the CNS was diminishing at the time
of death (Fig. 2C), consistent with a role for the host immune
response in both virus clearance and disease. When we
immunophenotyped mononuclear cell infiltrates from HCoV-
OC43NV-infected mice 7 days postinfection, we found that a
large fraction consisted of CD4 and CD8 T cells (Fig. 4A). Oned intranasally with 30 LD50 of HCoV-OC43NVand brains and spinal cords were
igen staining or Luxol Fast Blue (LFB) staining and slides were examined with
ethods. (A–B) HCoV-OC43 antigen is localized in the gray matter of spinal
i-OC43 S hybridoma O.4.3. Panel B depicts a serial section stained with LFB to
consistent with that of neurons. Images are representative coronal sections of
wed by Cy3-labeled goat anti-mouse. (F–H) Combination in situ hybridization
histochemistry for the astrocyte marker GFAP (FITC-labeled anti-GFAP, green).
tion for panels A and B, or 40 magnification for panels C–H.
Fig. 4. T cell infiltration into the HCoV-OC43NV-infected CNS contributes to morbidity and mortality. (A) Both CD4 and CD8 T cells infiltrate the brains of HCoV-
OC43NV-infected mice. Mononuclear cells were harvested 7 days p.i., surface stained for CD4 and CD8 and subjected to FACS analysis as described in Materials and
methods. Data from one representative mouse are shown. (B) Two color FACS analysis of in vitro peptide-stimulated mononuclear cells demonstrating infiltration of
OC43-specific CD4 T cells. Whole brains were isolated from HCoV-OC43NV-infected mice 7 days p.i. Mononuclear cells were surface stained for CD4 and
intracellularly stained for IFN-g ex vivo after no stimulation (left panel) or stimulation with M133 peptide (right panel). Data from one representative mouse are
shown. (C) HCoV-OC43NV-infected RAG1
/ C57BL/6 mice lose weight (left panel) and succumb to infection (right panel) with delayed kinetics relative to
infected wild type mice (*Indicates P < 0.05). (D) Relative burden of HCoV-OC43 RNA (left panel) and infectious virus (right panel) in brains of moribund wild
type and RAG1/ mice. Data in panel C are expressed as mean T SEM for 4–6 mice per group. (*Indicates P < 0.05).
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C57BL/6 mice is known, spanning residues 133–147 of the
transmembrane (M) protein (epitope M133). Identification of
this epitope was based on sequence homology with MHV. We
found that 1–3% of the infiltrating CD4 T cells at day 9
recognized this epitope (Fig. 4B). By contrast, 20–25% of
CD4 T cells in the MHV-infected CNS responded to epitope
M133 at 7 days p.i. (Haring et al., 2001). No HCoV-OC43 CD8
T cell epitopes have been identified yet so the magnitude of the
virus-specific CD8 T cell response could not be determined.
To probe the role of the host adaptive immune response in
pathogenesis, we infected immunodeficient mice lacking
normal T and B cell responses (mice with genetic disruption
of the recombination activating gene 1 (RAG1/)) and
monitored these mice for weight loss and survival. HCoV-
OC43NV-infected RAG1
/ mice developed signs of enceph-alitis (lethargy, hunching and weight loss) similar to those
observed in infected wild type mice, but with delayed kinetics
(Fig. 4C, left panel). Infected RAG1/ mice also survived
longer than did their B6 counterparts (Fig. 4C, right panel). At
the time of death, virus loads were 5–7-fold higher than
detected in moribund B6 mice, when measured by real-time
RT-PCR (Fig. 4D, left panel) or infectious virus titers (Fig. 4D,
right panel). At this time, viral antigen or RNA, detected by
immunohistochemistry or in situ hybridization, was detected
primarily in the brainstem although more cells were infected
than in B6 mice. As in wild type C57BL/6 mice, neurons were
the primary target for infection, suggesting that the antiviral
immune response was not responsible for the lack of infection
of glial cells (data not shown).
To confirm the pathological role of T cells, we adoptively
transferred HCoV-OC43-immune cells to RAG1/ mice that
N. Butler et al. / Virology 347 (2006) 410–421 415had been infected with 30 LD50 HCoV-OC43NV intranasally 4
days earlier. HCoV-OC43NV-infected RAG1
/ animals that
received no cells died by days 16–18, in line with experiments
described above. In contrast, the adoptive transfer of HCoV-
OC43-immune splenocytes to RAG1/ mice resulted in death
of recipient animals by days 11–13 (data not shown).
Divergent spike glycoprotein gene sequences between mouse
CNS-adapted, tissue culture-adapted and primary clinical
isolates of HCoV-OC43
While HCoV-OC43NV causes lethal encephalitis that is
enhanced by the antiviral T cell response, the results described
above show that HCoV-OC43TC is severely attenuated in mice
(Fig. 1). HCoV-OC43QUE was reported to cause less severe
disease than we observed in mice infected with HCoV-
OC43NV. These differences in neurovirulence prompted us to
determine the sequence of the S glycoproteins of HCoV-
OC43NV and HCoV-OC43TC and compare them to the
published HCoV-OC43QUE sequence, since the coronavirus S
protein is often associated with virulence (Thorp and Galla-
gher, 2004). Included in this comparison are all available
sequences submitted for a number of HCoV-OC43 isolates.
These additional isolates represent strains that were reported as
having been minimally or extensively passaged in tissue
culture cells, as well as several primary clinical isolates that
were never passaged in tissue culture cells (Supplementary Fig.
1). The sequence alignment revealed substantial divergence in
the primary amino acid sequence of these HCoV-OC43
isolates. Of note, there were three amino acid substitutions
wholly unique to HCoV-OC43NV (Table 1). Multiple other
differences between the HCoV-OC43TC and HCoV-OC43QUE
or HCoV-OC43NV strains are also present in both the S1 and
S2 domains (Supplementary Fig. 1). The large number of
differences will make it difficult to determine which substitu-
tions are critical for tissue culture cell adaptation. Of note,
sequencing of the 3Vterminal end of HCoV-OC43NV, includingTable 1
Comparison of S protein sequences from HCoV-OC43NV, HCoV-OC43QUE and
HCoV-OC43TC
S protein residuea HCoV-OC43NV HCoV-OC43QUE
b HCoV-OC43TC
33 (31,33) Serine Threonine Threonine
491 (489,495) Histidine Asparagine Asparagine
759 (757,765) Histidine Arginine Arginine
Virus passage
history
Only in
suckling
mouse brain
5–6 times in
HRT-18 cells
Extensively
(>10) in
HRT-18 cells
Neurovirulence Uniformly lethal
to adult mice
Lethal only
to young
(<21 days) micec
Avirulent
in miced
a S protein residue numbering is based on HCoV-OC43NV strain, with the
corresponding residues for HCoV-OC43QUE and HCoV-OC43TC in parenthe-
ses. S1 and S2 encompass amino acids 1–759 and 760–1353 to 1365,
respectively.
b The sequence for HCoV-OC43QUE corresponds to GenPept accession
number AAT84362, submitted by St-Jean et al. (St-Jean et al., 2004).
c Jacomy and Talbot (2003).
d Fig. 1.genes encoding non-structural 12.9 kDa, the small envelope
(E), the nucleocapsid (N) and the transmembrane (M) proteins
and the 3V untranslated region, revealed no nucleotide differ-
ences between HCoV-OC43NV and HCoV-OC43QUE.
Broad species and cell-type tropism of HCoV-OC43TC and
HCoV-OC43NV
As described above, HCoV-OC43 differs from most strains
of coronaviruses in that it readily crossed species barriers to
infect mice (McIntosh et al., 1967). This observation raised that
possibility that HCoV-OC43, unlike most other coronaviruses,
is able to infect a wide variety of species without substantial
adaptation. To gain insight into this possibility, we infected a
variety of tissue culture cells from a wide range of species
(hamster, pig, human, mouse, rat, monkey and cat) with HCoV-
OC43NV or HCoV-OC43TC. As shown in Fig. 5, immunocy-
tochemical staining for viral antigen revealed that the tissue
culture-adapted virus infected hamster, pig, human, mouse,
monkey and cat cells, but not FRT rat epithelium cells. The
neurovirulent strain also exhibited a wide host range specific-
ity, infecting hamster, pig, human, monkey, cat and mouse
cells. For some cells lines, such as murine 17CL-1, and human
KB and HT1080 cells, we detected infection only by the tissue
culture-adapted variant. Thus, both HCoV-OC43NV and HCoV-
OC43TC showed broad species specificity, and not surprisingly,
HCoV-OC43TC showed enhanced ability to infect all types of
tissue culture cells. Whether animals from these various species
are also infectable by HCoV-OC43 remains to be determined,
although data suggesting a close relationship between HCoV-
OC43 and BCoV (Vijgen et al., 2005b) make it likely that the
virus would be able to infect other species after minimal
adaptation.
Discussion
HCoV-OC43, as demonstrated herein, infects many cell
types and readily adapts to cause a virulent infection in mice
(Jacomy and Talbot, 2001, 2003) (Fig. 1). BCoV, which is
closely related to HCoV-OC43, also infects mice (Akashi et al.,
1981; Barthold et al., 1990); phylogenetic analyses suggest that
the two viruses diverged as recently as 1891 (Vijgen et al.,
2005b). These results suggest that HCoV-OC43 or BCoV
crossed species from either humans or bovine to infect the
other species, although the direction of spread is not known.
This ability to cross species is also shared by SARS-CoV.
SARS-CoV spread from exotic animals, most likely palm civet
cats, to humans during contacts in ‘‘wet markets’’ in China
(Peiris et al., 2004). Also, as part of efforts to study the
pathogenesis of this virus and to develop vaccines, several
animal species, including mice, cats, ferrets and monkeys were
shown to be susceptible to infection with the virus (Peiris et al.,
2004). SARS-CoV did not cause reproducible disease in any of
these species, suggesting that further adaptation was required
for optimal virus replication in these heterologous species.
HCoV-OC43 and SARS-CoV differ from many coronaviruses,
exemplified by HCoV-229E, in their ability to cross species.
Fig. 5. Broad tissue and cell type tropism of HCoV-OC43. Awide variety of tissue culture cells from hamster, rat, pig, human, mouse, monkey and cat were infected with 10 TCID50 (10
5 SMLD50) of HCoV-OC43NV,
30 TCID50 of HCoV-OC43TC or mock-infected as described in Materials and methods. After 3 days, virus-infected cells were detected with immunocytochemistry as described in Materials and methods. Nearly all of
the cell lines were infected with both viruses, demonstrating that HCoV-OC43 exhibits a broad species specificity in vitro. Original images are 20 magnification.
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N. Butler et al. / Virology 347 (2006) 410–421 417HCoV-229E, a human respiratory virus, does not infect mice or
even mice transgenic for human aminopeptidase N (hAPN), the
HCoV-229E host cell receptor (Wentworth et al., 2005).
However, infection occurs, albeit with mild clinical disease if
virus is adapted for growth in murine cells expressing hAPN
and if mice are deficient in type I interferon responses (Lassnig
et al., 2005).
SARS-CoV and HCoV-OC43, while both able to cross
species, differ in regard to host cell receptor usage. The primary
receptor for SARS-CoV is angiotensin converting enzyme 2
(ACE2) and other molecules such as DC-SIGN serve to
enhance binding to target cells (Jeffers et al., 2004; Li et al.,
2003; Marzi et al., 2004). Adaptation to growth in foreign
species involves mutations that enhance binding to heterolo-
gous ACE2 (Li et al., 2005). No proteinaceous receptor for
HCoV-OC43 has been conclusively identified; rather, O-
acetylated sialic acid or a closely related compound appears
to serve as the host cell receptor (Schultze and Herrler, 1992;
Vlasak et al., 1988). While little is known about the changes
required for efficient replication of HCoV-OC43 in the murine
CNS, it is likely that this process includes mutations that affect
binding to host cell sugar moieties. Infection with the
prototypic alphavirus, Sindbis virus (SINV), or with a
picornavirus, Theiler’s murine encephalomyelitis virus
(TMEV), is initiated by binding to a polyanionic polysaccha-
ride, heparin sulfate (Byrnes and Griffin, 1998; Klimstra et al.,
1998; Reddi and Lipton, 2002). SINV with enhanced binding
to heparin sulfate is selected after passage in tissue culture
cells. HCoV-OC43 may undergo a similar set of changes
during the course of adaptation to growth in tissue culture cells.
The S protein of HCoV-OC43TC differs from that of HCoV-
OC43NV at 20 positions (Supplementary Fig. 1), making it
difficult to determine which ones might contribute to enhanced
ability to replicate in tissue culture cells.
By contrast, HCoV-OC43NV includes a limited number of
amino acids that are not present in any S proteins described in
the literature (Table 1 and Supplementary Fig. 1). In all
laboratory isolates of HCoV-OC43, viruses encoding these
proteins were passaged at least a few times in tissue culture
cells (Kunkel and Herrler, 1993b; Kunkel and Herrler, 1996;
Mounir and Talbot, 1993; St-Jean et al., 2004; Vijgen et al.,
2005b). While no two sequences are identical, three substitu-
tions, T33S, N491H and R759H, are unique to the HCoV-
OC43NV strain (Table 1 and Supplementary Fig. 1). The
receptor binding domain of HCoV-OC43 has not been defined,
but both T33S and N491H are in regions important for receptor
binding by other coronaviruses (e.g., Saeki et al., 1997; Xiao et
al., 2003). Thus, these two changes could potentially alter the
association or stability between HCoV-OC43NV and host cell
receptors in the murine CNS.
In other coronaviruses, cleavage of S into S1 and S2
domains is required for optimal virus replication. For
example, disruption of the S1–S2 cleavage site in MHV
resulted in a viable virus that was attenuated for growth in
tissue culture cells and mice (Stauber et al., 1993; Taguchi,
1993). On the other hand, studies in BCoV revealed no
correlation between the presence of the furin cleavage motifand virulence (Zhang et al., 1991). Of the several laboratory
isolates of HCoV-OC43 that have been sequenced, most
contain the sequence RRSRG at the putative furin cleavage
site. Kunkel and Herrler showed that S proteins containing
this motif are not cleaved in infected cells, whereas two
strains (designated OC43-CU and OC43-VA, Supplementary
Fig. 1) in which the S gene encoded a prototypic cleavage
site (RRSRR) were cleaved (Kunkel and Herrler, 1993a). The
sequences of seven recently described primary clinical isolates
also share the RRSRR motif (Supplemental Fig. 1) (Vijgen et
al., 2005a). Whether or not these primary isolates are cleaved
and whether this motif contributes to clinical disease in
humans are not known. As reported herein, the S protein of
HCoV-OC43NV contains the sequence RRSHG and presum-
ably is not cleaved to a significant extent because it contains
a glycine at position 5; it is even less likely that HCoV-
OC43TC, in which the sequence at this site is IRSRG, is
cleaved. Although the R759H substitution is unlikely to affect
cleavability of HCoV-OC43NV S, as this is a conserved
(charged-basic to charged-basic) change, it is formally
possible that this unique substitution could alter cleavage
and contribute to the enhanced virulence of HCoV-OC43NV.
The position of these 3 mutations (T33S, N491H, and
R759H) is consistent with a role in virulence, but to prove
definitively their role in disease enhancement, it will be
necessary to introduce these changes into the HCoV-OC43
genome. This will require a reverse genetics system. An
infectious clone for HCoV-OC43 has not yet been reported, but
it is likely that one or more infectious cDNA clones will be
available in the near future.
While a comparison of our results with those of Jacomy et
al. suggest that HCoV-OC43NV is more virulent than HCoV-
OC43QUE, both strains show a tropism for neurons (Jacomy
and Talbot, 2003). Direct virus destruction of infected neurons
is clearly important for much of the disease observed in mice
infected with HCoV-OC43NVor HCoV-OC43QUE; even though
death is delayed in infected RAG1/ mice compared to wild
type mice, all mice still die by 16 days p.i. (Fig. 4). However,
the delayed death of infected RAG1/ mice suggests that
HCoV-OC43-induced encephalitis is in part mediated by the
antiviral T cell response. Of note, Jacomy et al. previously
concluded that the adaptive immune response did not
contribute to pathology associated with HCoV-OC43 infection,
based on the observation that treatment of mice with
cyclosporin (CsA) prior to infection resulted in more rapid
onset of disease and an increase in the percentage of mice that
succumbed to the virus (Jacomy and Talbot, 2003). These
contrasting results may result from the different mechanisms of
immunosuppression observed in RAG1/ and CsA-treated
mice.
Neurons do not normally express MHC class I or II antigen
and express only low levels of the machinery required for
loading peptide onto MHC class I antigen (Joly and Oldstone,
1992). However, electrically silent or damaged neurons do
express MHC class I antigen (Medana et al., 2000; Neumann et
al., 1995, 1997) and it is possible that infection with HCoV-
OC43 makes neurons into suitable targets for CD8 T cells. Of
N. Butler et al. / Virology 347 (2006) 410–421418note, even damaged neurons have never been reported to
express MHC class II antigen, making a direct effect of CD4 T
cells on infected neurons unlikely. However, CD4 T cells are
required for optimal function of CD8 T cells in the MHV-
infected CNS (Stohlman et al., 1998). Sindbis virus (SINV), a
prototypic alphavirus, also primarily affects neurons. While
virus clearance is largely mediated by antiviral antibodies, T
cells, by secreting IFN-g, are critical for clearance from spinal
cord neurons (Binder and Griffin, 2001). Similar mechanisms
may be involved in virus clearance from HCoV-OC43 neurons,
with subsequent immunopathology. Future studies, directed at
determining whether antiviral CD4 and CD8 T cell responses
contribute to both virus clearance and to severe disease in
HCoV-OC43-infected mice, may also be relevant to under-
standing disease outcome in patients with SARS, since neurons
are infected in some patients (Gu et al., 2005).
Materials and methods
Viruses and cell lines
HCoV-OC43NVand HCoV-OC43TC (VR-759 and VR-1558,
respectively), as well as the cell lines 17Cl-1, L929, HeLa and
AK-D, were obtained from the ATCC (Manassas, VA). FRT,
CHO-K1 and LLCK-PK cells were a generous gift from Dr.
Michael Welsh, University of Iowa. HT-1080 and KB cells
were a generous gift from Dr. Paul McCray, University of
Iowa. HCoV-OC43 VR-759 was propagated in suckling mouse
brain. HCoV-OC43 VR-1558 was propagated in HRT-18 cells.
Mice
Pathogen-free male C57BL/6 mice were purchased from the
National Cancer Institute (Bethesda, MD). RAG1/ and
suckling Swiss mice were obtained from breeding colonies
maintained by our laboratory. For intranasal infection, 5- to 8-
week-old mice were lightly anesthetized with halothane and
droplets containing 30 LD50 (10
7 SMLD50) of HCoV-OC43NV
or 106 TCID50 of HCoV-OC43TC were administered to the
nares. All procedures used in this study were approved by the
University of Iowa Institutional Animal Care and Use
Committee.
Antibodies and reagents
Monoclonal antibodies recognizing murine glial fibrillary
acidic protein (GFAP) or murine F4/80 were purchased from
Dako (Carpinteria, CA) and Caltag (Burlingame, CA), respec-
tively. Monoclonal antibody (mAb) directed against the surface
glycoprotein of OC43 was prepared from the hybridoma O.4.3,
a generous gift from Dr. John O. Fleming, University of
Wisconsin, Madison, WI.
Cell culture infection
Cells were maintained in the appropriate growth medium
at 37 -C in 5% CO2. For OC43 infection, cells were washedtwice with PBS, and virus was adsorbed for 2 h at 33 -C in
Dulbucco’s Modified Eagle’s Medium (serum-free DMEM) +
15 mM HEPES, pH 7.5. Cells were infected with 30 TCID50
of HCoV-OC43TC (based on infection of HRT-18 cells) or
105 SMLD50 (approximately 10 TCID50 based on infection
of HRT-18 cells). Virus suspensions were aspirated and
medium containing 2% fetal bovine serum was added to
cells. Cells were then cultured for an additional 2–5 days at
33 -C.
Determination of viral titers
Whole brains were aseptically removed from mice at
various times postinfection, homogenized in sterile PBS and
clarified by centrifugation. 20 Al of serial log10 dilutions of
brain homogenates was inoculated intracranially into 2- or 3-
day-old Swiss pups. Survival was monitored and viral titers
were calculated using the formula of Karber: Negative log of
the lowest dilution  [(sum of percentage positive / 100) 
0.5]  log interval. Virus titers are expressed as the reciprocal
of the highest dilution where the virus suspension killed 50%
of inoculated suckling mice (SMLD50).
Virus antigen detection
For immunohistochemistry, brain and spinal cord sections
were processed as previously described (Pewe et al., 2002).
Primary antibody was mouse anti-S mAb (O.4.3) and
secondary antibody was biotinylated goat anti-mouse. Sec-
tions were developed by sequential incubation with strepta-
vidin–horseradish peroxidase (HRP) conjugate and DAB
(Sigma, St Louis, MO) or streptavidin–Cy3 reagent (Jackson
ImmunoResearch, West Grove, PA). For immunocytohem-
istry of OC43-infected adherent cells, samples were fixed for
30 min in 10% formalin, rinsed with 100 mM glycine and
permeabilized in 0.5% Triton X-100. Wells were blocked
with 10% NGS and incubated with O.4.3 overnight at 4 -C.
Wells were developed as described above.
In situ hybridization
8 Am brain and spinal cord sections were prepared as
described above and in situ hybridization for viral RNA was
performed using a protocol adapted from Gene Detect (Auck-
land, New Zealand). Briefly, formalin fixed, paraffin embedded
tissue sections were permeabilized for 30 min at 37 -C in 250
Ag/ml pepsin in 200 mM HCl and then blocked with
prehybridization buffer for 2 h at 37 -C. 3V-biotinylated,
HCoV-OC43-specific oligonucleotide probes (antisense 5V–3V,
GTATTGACATCAGCCTGGTTGCTAG; sense 5V–3V, CTAG-
CAACCAGGCTGATGTCAATAC) were added to a final
concentration of 200 ng/ml and sections were incubated for
18 h at 37 -C. After several washes of increasing stringency,
streptavidin–HRP conjugate was added for 1 h at 25 -C
followed by tyramide signal amplification (TSA) cyanine 3
reagent (Perkin Elmer, Boston, MA). For some experiments,
slides were also stained with anti-GFAP followed by FITC-
N. Butler et al. / Virology 347 (2006) 410–421 419conjugated goat anti-rabbit secondary antibody prior to
developing with TSA-Cy3 reagent. Sections were examined
with a Bio-Rad (Hercules, CA) LaserSharp2000 confocal
microscope.
Real-time RT-PCR
Total RNA was isolated using Tri Reagent (Molecular
Research Center, Cincinnati, OH) following the manufacturer’s
instructions. 2 Ag of total RNAwas reverse transcribed to cDNA
using RETROscript RT-PCR Kit (Ambion, Austin, TX)
according to the manufacturer’s instructions. The resulting
cDNA was subjected to PCR as follows. 2 Al of cDNA was
added to a 23 Al PCR cocktail containing 2 SYBR Green
Master Mix (Applied Biosystems, Foster City, CA) and 0.2 AM
of each sense and antisense primers (Intergrated DNA
Technologies, Coralville, IA). Amplification was then per-
formed in an Applied Biosystems Prism 7700 thermocycler.
Specificity of the amplification was confirmed using melting
curve analysis. Data were collected and recorded by the Prism
7700 software and expressed as a function of Threshold Cycle
(Ct). Specific primer sets used for HCoV-OC43 and murine
housekeeping gene are as follows (5V to 3V); HCoV-OC43
nucleocapsid forward, GGTCTCAACCCCCAGCTAGT;
OC43 nucleocapsid reverse, TGATGCTCTTTAGGCTTTCCA;
HPRT forward, CCTCATGGACTGATTATGGAC; HPRT re-
verse, CAGATTCAACTTGCGCTCATC. HCoV-OC43 nucle-
ocapsid RNA abundance was calculated using methods
described previously (Pewe et al., 2005).
Sequencing
Total RNA from infected murine brain or A549 cells
was reverse transcribed to cDNA. Primers were designed
(based on GenBank accession number AY585228) to
generate overlapping amplimers, ensuring complete coverage
of the S genes of HCoV-OC43NV and HCoV-OC43TC, as well
as 3V terminal end of the HCoV-OC43NV genome. PCR
products were sequenced directly by the University of Iowa
DNA Core.
Flow cytometry
Single cell suspensions of mononuclear cells from whole
brain homogenates were prepared as previously described
(Pewe et al., 2005). Fc receptors were blocked with normal
rat serum and anti-CD16/CD32 (clone 2.4G2, BD Bios-
ciences, San Jose, CA). Antibodies used to phenotype cells
were fluorescein isothiocyanate-labeled anti-mouse CD4 and
phycoerythrin-labeled anti-mouse CD8 (clones GK1.5 and
53–6.7, BD Biosciences, Mountain View, CA). CD4 T cells
recognizing an HCoV-OC43-specific CD4 T cell epitope
M133 (spanning residues 133–147 of the M protein) were
identified using intracellular cytokine staining as previously
described (Wu et al., 2000). Samples were analyzed on a
FACScan flow cytometer (BD Biosciences, Mountain View,
CA).Statistics
Statistical analysis was done with unpaired (two-tailed) t
tests. Values in figures are expressed as mean T SEM. Values of
P < 0.05 were considered significant and are indicated by an
asterisk (*) in figures.
Appendix A. Supplementary data
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.virol.2005.11.044.
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